In vitro and in vivo activity of cyclopeptide Dmt-c[ d -Lys-Phe-Asp]NH 2 , a mu opioid receptor agonist biased toward β-arrestin
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Polpharma Scientific Foundation (11/XIII/2014)
- Medical University of Lodz (502-03/1-156-02/502-14-301, 503/1-156-02/503-11-002)
- University of Ferrara
This publication has 56 references indexed in Scilit:
- Mu-Opioid receptor biased ligands: A safer and painless discovery of analgesics?Drug Discovery Today, 2017
- Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administrationEuropean Journal of Medicinal Chemistry, 2016
- Potent Biphalin Analogs with µ/δ Mixed Opioid Activity:In VivoandIn VitroBiological EvaluationArchiv der Pharmazie, 2014
- Chimeric G Proteins in Fluorimetric Calcium Assays: Experience with Opioid Receptors2012
- Opioid receptor signaling: relevance for gastrointestinal therapyCurrent Opinion in Pharmacology, 2006
- Synthesis and biological activity of the first cyclic biphalin analoguesBioorganic & Medicinal Chemistry Letters, 2006
- Antinociceptive interactions of opioid delta receptor agonists with morphine in mice: Supra- and sub-additivityLife Sciences, 1992
- Topographical requirements for delta opioid ligands: Common structural features of dermenkephalin and deltorphinLife Sciences, 1992
- Double-enkephalins—Synthesis, activity on guinea-pig ileum, and analgesic effectPeptides, 1982
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973